|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8-9
|
|
pubmed:dateCreated |
2011-5-16
|
|
pubmed:abstractText |
Receptor for advanced glycation end products (RAGE) plays a role in inflammatory reactions. Soluble RAGE (sRAGE) level is elevated in patients with acute respiratory distress syndrome (ARDS). However, which clinical parameters and inflammatory biomarkers including sRAGE are associated with death in ARDS patients remain unknown.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1873-2933
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2010 Elsevier B.V. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
601-4
|
|
pubmed:meshHeading |
pubmed-meshheading:21211520-Aged,
pubmed-meshheading:21211520-Female,
pubmed-meshheading:21211520-HMGB1 Protein,
pubmed-meshheading:21211520-Humans,
pubmed-meshheading:21211520-Interleukin-6,
pubmed-meshheading:21211520-Male,
pubmed-meshheading:21211520-Middle Aged,
pubmed-meshheading:21211520-Mucin-1,
pubmed-meshheading:21211520-Receptors, Immunologic,
pubmed-meshheading:21211520-Respiratory Distress Syndrome, Adult
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome.
|
|
pubmed:affiliation |
Division of Nephrology, Department of Internal Medicine, Shinmatsudo Central General Hospital, Matsudo 270-0034, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
